Skip to main content


Springer Nature is making Coronavirus research free. View research | View latest news | Sign up for updates

Figure 1 | Journal of Intensive Care

Figure 1

From: Prognosis of patients with fulminant myocarditis managed by peripheral venoarterial extracorporeal membranous oxygenation support: a retrospective single-center study

Figure 1

Serial changes of markers during extracorporeal membranous oxygenation support. (a) White blood cell (WBC), (b) glutamic oxaloacetic transaminase (GOT), (c) glutamic pyruvic transaminase (GPT), (d) lactate dehydrogenase (LDH), (e) total bilirubin, (f) direct bilirubin, (g) blood urea nitrogen (BUN), and (h) creatinine. There were no significant differences between the survivor group and non-survivor group, except for in the serum bilirubin levels. The serum total and direct bilirubin levels on day 7 in the survivor group were significantly lower compared with those on day 7 in the non-survivor group (total bilirubin: 4.6 ± 2.8 vs. 13.7 ± 10.8 mg/dL, p = 0.014; direct bilirubin: 2.2 ± 0.5 vs. 9.8 ± 4.5 mg/dL, p = 0.009).

Back to article page